ADMA — ADMA BIOLOGICS INC

Ownership history in Man Group plc · 7 quarters on record

This page tracks every 13F SEC filing in which Man Group plc reported a position in ADMA BIOLOGICS INC (ADMA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

0.03% (2024 Q4)

Avg. % of fund

0.01%

First filed

2022 Q1

Last filed

2025 Q3

Quarters held

7

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q3	REDUCED	24,319	-104,099	-81.1%	0.00%	$357K	$14.66
2025 Q2	REDUCED	128,418	-29,727	-18.8%	0.00%	$2.3M	$18.21
2025 Q1	REDUCED	158,145	-587,155	-78.8%	0.01%	$3.1M	$19.84
2024 Q4	ADDED	745,300	+561,507	+305.5%	0.03%	$12.8M	$17.15

% of Fund (quarterly) ADMA price (monthly, adj. close)

Other funds also holding ADMA

As of 2025 Q4 — sorted by position size

B Group, Inc. 33.1% Stonepine Capital Management, LLC 3Y 7Y 9.85% Sachem Head Capital Management LP 3Y 7Y 4.86% Caligan Partners LP 3Y 4.52% AWM Investment Company, Inc. 3Y 7Y 3.87% Ranger Investment Management, L.P. 3Y 7Y 2.88% PFM Health Sciences, LP 3Y 7Y 2.31% MARATHON CAPITAL MANAGEMENT 3Y 7Y 1.83% Catalio Capital Management, LP 1.82% FINDELL CAPITAL MANAGEMENT LLC 1.57%

← Back to Man Group plc Holdings